Related Experiment Video
Updated: Jul 5, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Using Detective Skills: Getting to the Bottom of Dual Antiplatelet Therapy
11 Consultant, Collaborative Pharmacy Consulting, Lehi, Utah.
Abstract:
Consultant pharmacists have always been effective at identifying patients at high risk for bleeding. Their training qualifies them to do more than just identify. Early in the author's career, he was trained to look for dual antiplatelet therapy (DAPT) and recommend monitoring for signs and symptoms of bleeding in those identified. He used this method for several months before a nurse called him out and asked, "Why do you send us recommendations to monitor for bleeding?" She explained that this was a routine part of nursing assessments, regardless of the presence of DAPT. That's when he realized that the recommendation was like telling a pharmacist not to crush an extended-release formulation of a medication. It was duplicating the work of other health care professionals, undervaluing their expertise, and counterproductive to a team-based approach.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

